Member Info for Flippineck

In the RNS of 28 April it said median PFS had not been reached, with median follow up exceeding 5.9 months, compared to recent benchmarking presented at ESMO 2024 of 3.5 months.

All being well, by the end of May there could be virtually a doubling of PFS to 7 months. That would be quite a milestone.

Brilliant posts NFTs. Thank you.

I remember the scientists saying in one presentation that they wanted to be “ masters of FAP”, or something like that. I think the long trial period, whilst criticised by many, has worked to our advantage and produced a wealth of valuable data.

GLA

CC and the scientists sound confident and optimistic. Data coming in every week. Top people on Scientific Advisory Board. Heights don’t appear to be selling in the usual manner. Share price creeping up. A few numpties popping up.

A few dots to join up? You either believe we have something special or you don’t.

GLA

“ Complete lack of mention of Soft Tissue Sarcomas is surely concerning ?”

Why don’t you bother to properly read RNS’s before coming out with such daft statements?

Another excellent communication. Well worth watching.

Tim, I know it’s been said before but

May the 4th be with you.

Is that a big buy at 12.22?

L.E.K. and Tempus both good collaborations.

The Frog seems to have made up his mind already. Time for him to hop off, I think. Bon voyage.

The RNS was largely as expected.

Despite a flock of doomsters landing on the lawn this morning we have more buys than sells so far. Some quite sizeable buys have appeared over recent days.

Looking forward to AACR.

This RNS is as we expected.

Sam, perhaps pop back here in 3 months?

Good to see a couple of chunky buys this morning. Looking forward to AACR news.

Exactly B2HS2L. BG needed to put a label on the reason for selling but there are other possibilities/likelyhoods.

It’s a shame when a poster sinks to the level of personal insults. Very poor form.

Looking forward to AACR in a few days time for latest news.

Not fussed re BG decision, people buy and sell all the time and reasons given for selling are not always the true reasons. We are living in difficult times.

We certainly seem to have a bit of a spring in our step today.

Wyn - ever heard of “bed and isa”?

Touk. Talk about being economical with the truth!

Your post yesterday at 08.43 is there for all to see. Why have you chosen to only repost the second part of your post?

Your first sentence stated “ Oh well the good news for you is that at least you will be limiting your loss to only another £20k”.

You have no idea how much I will be investing in my 2025 ISA. Neither have you any idea how my money will be divided between different investments. Part of it will be AVCT.

Perhaps you should re-read my post of 08.38.

You were so frantic in your posting yesterday you seem to have lost touch with reality. Goodbye.

Touk, your assumptions about me and my ISA actions are about as accurate as your posts.

The opportunity here is in adapting existing drugs to greatly improve targeted cancer treatments.

To be able to do this effectively, more cheaply and with significantly lower manufacturing costs has to be a winner.

Our collaboration with Tempus has allowed us to choose patients and cancer types which will give the best chance of success in phase 1b. That will hopefully speed up commercialisation.

I fully support our board and scientists and will be adding new shares into my ISA next week.

GLA